Article révisé par les pairs
Titre:
  • Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma
Auteur:Bajetta, Emilio; Di Leo, Angelo; Zampino, Maria Giulia; Sertoli, Mario Roberto; Comella, G; Barduagni, Mario; Giannotti, Benvenuto; Queirolo, Paola; Tribbia, Giuliana; Bernengo, Maria Grazia Razia; Menichetti, Ettore Tito; Palmeri, Sergio; Russo, Annapina; Cristofolini, Mario; Erbazzi, Anna; Fowst, Camilla; Criscuolo, Domenico; Bufalino, Rosaria; Zilembo, Nicoletta; Cascinelli, Natale
Informations sur la publication:Journal of clinical oncology, 12, 4, page (806-811)
Statut de publication:Publié, 1994
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Dacarbazine -- administration & dosage -- adverse effects -- therapeutic use
Female
Humans
Interferon-alpha -- administration & dosage
Male
Melanoma -- drug therapy -- secondary
Middle Aged
Recombinant Proteins
Skin Neoplasms -- drug therapy -- pathology
Survival Analysis
Treatment Outcome
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:scp/0028218050
info:pmid/8151323
VX-005563

Documents en relation

DI-fusion